|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1R01DA059457-01A1 |
A Growing Crisis of Novel Injection-Related Wounds and Skin & Soft Tissue Infections among People Who Inject Drugs: A Community-Based, Longitudinal Investigation in North Carolina |
RESEARCH TRIANGLE INSTITUTE |
NIDA |
$416,715 |
$244,298 |
$661,013 |
| 1R01HD112407-01A1 |
Clinical progression and predictors of outcomes in congenital Zika syndrome |
RESEARCH TRIANGLE INSTITUTE |
NICHD |
$500,465 |
$112,275 |
$612,740 |
| 1R01MH135136-01 |
In Vivo Probes of Mas1 Receptor |
RESEARCH TRIANGLE INSTITUTE |
NIMH |
$264,601 |
$372,040 |
$636,641 |
| 1R01MH137006-01 |
Development and Testing of a Pediatric Anxiety Outcomes Quality Measure (PAO_QM Study) |
RESEARCH TRIANGLE INSTITUTE |
NIMH |
$382,881 |
$96,007 |
$478,888 |
| 1R01MH137804-01 |
CARES: An adherence support intervention for multiple PREP methods among adolescent girls and young women in South Africa and Zimbabwe |
RESEARCH TRIANGLE INSTITUTE |
NIMH |
$569,698 |
$140,489 |
$710,187 |
| 1R01MH137873-01 |
Improving Choice and Use of Biomedical HIV Prevention for Women in Uganda: A Couples-Based Approach |
RESEARCH TRIANGLE INSTITUTE |
NIMH |
$598,750 |
$184,363 |
$783,113 |
| 1R21DA060954-01 |
Community Mitigation Against Xylazine |
RESEARCH TRIANGLE INSTITUTE |
NIDA |
$158,681 |
$53,519 |
$212,200 |
| 1R21DA061167-01 |
Growing Xylazine Supply in NC: A Community-Based Investigation of Exposure and Health Consequences |
RESEARCH TRIANGLE INSTITUTE |
NIDA |
$157,455 |
$46,788 |
$204,243 |
| 1R21HD111729-01A1 |
Preventing Intimate Partner Violence Among Teens Who Are Pregnant or Parenting |
RESEARCH TRIANGLE INSTITUTE |
NICHD |
$150,000 |
$78,140 |
$228,140 |
| 1R21HD111933-01A1 |
Improving accessibility of virtual interventions for families of infants with neurogenetic conditions - Resubmission |
RESEARCH TRIANGLE INSTITUTE |
NICHD |
$179,000 |
$65,190 |
$244,190 |
| 1R21HG013558-01 |
Gene Selection for Newborn Sequencing Studies |
RESEARCH TRIANGLE INSTITUTE |
NHGRI |
$263,502 |
$152,210 |
$415,712 |
| 1R24ES036127-01 |
Data Standards to Support Integrated Source to Outcome Modeling |
RESEARCH TRIANGLE INSTITUTE |
NIEHS |
$501,067 |
$251,501 |
$752,568 |
| 1R61DA061296-01 |
'A friend in my pocket': mHealth intervention to reduce overdose risk among people who engage in polysubstance use |
RESEARCH TRIANGLE INSTITUTE |
NIDA |
$590,408 |
$383,909 |
$974,317 |
| 1U01HD115569-01 |
A Prospective Randomized Controlled Trial to Evaluate the Impact of Treatment of Asymptomatic Bacteriuria on Low Birth Weight |
RESEARCH TRIANGLE INSTITUTE |
NICHD |
$722,712 |
$105,609 |
$828,321 |
| 1U24HL166580-01A1 |
2/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) - DCC Resubmission |
RESEARCH TRIANGLE INSTITUTE |
NHLBI |
$733,930 |
$438,504 |
$1,172,434 |
| 1U24HL173304-01 |
2/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT) |
RESEARCH TRIANGLE INSTITUTE |
NHLBI |
$1,065,707 |
$332,214 |
$1,397,921 |
| 1U24MH137696-01 |
Preteen Suicide Risk and Protective Factors Data Coordinating Center |
RESEARCH TRIANGLE INSTITUTE |
NIMH |
$249,851 |
$207,827 |
$457,678 |
| 1U54HL178351-01 |
INCLUDE Down Syndrome Clinical Cohort Coordinating Center (DS-4C) |
RESEARCH TRIANGLE INSTITUTE |
NHLBI |
$1,322,252 |
$677,256 |
$1,999,508 |
| 1UG3AI181797-01 |
Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP) |
RESEARCH TRIANGLE INSTITUTE |
NIAID |
$4,464,479 |
$3,530,409 |
$7,994,888 |
| 272201800002I-0-759302400001-1 |
Task B30: Scale Up Synthesis of VKT-034 |
RESEARCH TRIANGLE INSTITUTE |
NIAID |
|
|
$85,231 |